Status:
COMPLETED
Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study
Lead Sponsor:
McGill University
Collaborating Sponsors:
Canadian Cancer Society (CCS)
Princess Margaret Hospital, Canada
Conditions:
Breast Neoplasms
Ovarian Neoplasms
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Studies show that cancer survivors have unmet needs, the most frequently cited being fear of recurrence (FCR). Moderate to high levels of FCR have been reported by as much as 49% of cancer patients an...
Detailed Description
The present study aims to further test this cognitive-existential group intervention for FCR in a randomized control clinical trial with women with breast or gynecological cancer. Participants will be...
Eligibility Criteria
Inclusion
- first diagnosis of BC or GC with stages between I-III;
- disease-free at the start of the group;
- women aged 18 years or older;
- completion of treatment, with the exception of adjuvant chemotherapy or hormonal replacement therapy
Exclusion
- non-English speakers
- previous cancer recurrence
- enrolled in another group psychotherapy at the time of the start of the study or during the course of the 6 sessions
- unresolved mental health disorder judged to be clinically contra-indicated and/or likely to affect the group work, based on disclosure by the potential participant or clinically identified by the group leader.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT03270995
Start Date
October 1 2014
End Date
February 1 2020
Last Update
February 20 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital
Ottawa, Ontario, Canada, K1H 8L6
2
Princess Margaret Hospital
Toronto, Ontario, Canada, M5G2C4
3
Jewish General Hospital
Montreal, Quebec, Canada, H3A 2A7